Authors
Rana F. Shayya, M.D., Marcus A. Rosencrantz, M.D., Sandy S. Chuan, M.D., Heidi Cook-Andersen, M.D., Ph.D., William E. Roudebush, Ph.D., H. I. Su, M.D., M.S.E.C., Shunichi Shimasaki, Ph.D., R. J. Chang, M.D.
Volume 101, Issue 1, Pages 275-279, January 2014
Abstract
Objective:
To determine whether granulosa cells contribute to excess androgen production, by assessing inhibin B (Inh B) responses to hCG in women with polycystic ovary syndrome (PCOS) and in normal women.
Design:
Prospective study.
Setting:
Academic medical center.
Patient(s):
Twenty women with PCOS and 16 normal women.
Intervention(s):
Blood samples obtained before and 24 hours after injection of 25 μg recombinant hCG (r-hCG).
Main Outcome Measure(s):
Basal and stimulated Inh B, E2, androstenedione (A), and T responses after r-hCG administration.
Result(s):
In normal and PCOS women, r-hCG induced a significant reduction of Inh B levels. Lowered Inh B responses were not related to body mass index, PCOS status, or age by multivariate regression. Recombinant hCG significantly increased serum A and E2 in both normal and PCOS women.
Conclusion(s):
In normal and PCOS women, Inh B production was decreased following r-hCG administration. These findings strongly suggest that in PCOS women androgen excess is not enhanced by LH-stimulated Inh B production.
Clinical Trial Registration Number:
NCT00747617.
Read the full text at: http://www.fertstert.org/article/S0015-0282(13)03111-7/fulltext
